Skip to content

Control group:basic therapy

16 trials

Sponsors

The First Hospital of China Medical University, Shanghai Municipal Hospital of TCM, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, The First Medical Center, Chinese PLA General Hospital, Affiliated Hospital of Yunnan University

Conditions

Acute exacerbation of bronchiectasisAlzheimer‘s diseaseCerebral infarctionChronic liver failureInterstitial lung diseaseType 2 Diabetesacute ischemic strokeamyotrophic lateral sclerosis

Early Phase 1

Clinical study on Yixiao Decoction in the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunction
RecruitingChiCTR2100045193
Dongzhimen Hospital Affiliated to Beijing University of Chinese MedicineType 2 Diabetes
Start: 2021-04-10Updated: 2021-11-08
Clinical study on Yixiao Decoction in the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunction
RecruitingITMCTR2100004708
Dongzhimen Hospital Affiliated to Beijing University of Chinese MedicineType 2 Diabetes
Start: 2021-04-10Updated: 2023-02-20
Fecal Microbiota Transplantation in the treatment of Alzheimer's disease
RecruitingChiCTR2100045955
The First Medical Center, Chinese PLA General HospitalAlzheimer‘s disease
Start: 2021-04-30Updated: 2021-12-13
Fecal microbiota transplantation in the treatment of amyotrophic lateral sclerosis
RecruitingChiCTR2100046015
The First Medical Center, Chinese PLA General Hospitalamyotrophic lateral sclerosis
Start: 2021-04-30Updated: 2021-12-13
Clinical Efficacy and Mechanism of Hyperbaric Oxygen in the Treatment of Acute Cerebral Infarction
Active, not recruitingChiCTR2100049959
Yellow River Central Hospital of Yellow River Water Conservancy Commissionthe acute cerebral infarction
Start: 2021-08-14Updated: 2022-04-19
Study on the clinical effecy and mechanism of KaiyuTongzhi method in treating metabolic syndrome
Active, not recruitingITMCTR2022000029
Guang'anmen Hosptialmetabolic syndrome
Start: 2022-07-01Updated: 2023-02-20
Clinical observation on reducing uric acid in treating gouty arthritis intermittent and hyperuricemia with Kang-acid tea
Active, not recruitingChiCTR2300070968
Yunnan Hospital of Traditional Chinese Medicine / The No.1 Affiliated Hospital of Yunnan University of Chinese Medicinegouty arthritis?hyperuricemia
Start: 2023-05-01Updated: 2023-06-04

Phase 4

Unknown Phase

Related Papers